Dual Myeloperoxidase (MPO)/PR3-Positive ANCA-Associated Vasculitis with Hypocomplementemia and Epstein-Barr Virus Viremia Presenting as Fulminant Pulmonary-Renal Syndrome (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #PUB161; "Cyclophosphamide provided effective induction while potentially reducing infectious risk compared with rituximab. Adjunctive avacopan facilitated glucocorticoid reduction in a critically ill patient."
ANCA Vasculitis • Cardiovascular • Epstein-Barr Virus Infections • Glomerulonephritis • Hematological Disorders • Hypertension • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Systemic Lupus Erythematosus • Vasculitis • MPO
|
|
Sheeraz Abro; Paras A. Abro; Ramya Krishna Velagapudi
|